References
- Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines CXC and CC chemokines. Advances in Immunology, 55: 97–179
- Casilli F, Bianchini A, Gloaguen I, Biordi L, Alesse E, Festuccia C, Cavalieri B, Strippoli R, Cervellera MN, Di Bitondo R, Ferretti E, Mainiero F, Bizzarri C, Colotta F, Bertini R. Inhibition of interleukin-8 (CXCL/IL-8) response by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2. Biochemistry and Pharmacology 2005; 69: 385–394
- Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharmacology Research 1993; 10: 1093–1095
- Dogterom P, Rothuizen J. A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs. Qualitative and quantitative sex differences. Drug Metabolism and Disposition 1993; 21: 705–709
- Ehlhardt WJ, Woodland JM, Toth JE, Ray JE, Martin DL. Disposition and metabolism of the sulfonylurea oncolytic agent LY295501 in mouse, rat and monkey. Drug Metabolism and Disposition 1997; 25: 701–708
- Gibaldi M, Perrier D. Pharmacokinetics2nd. Marcel Dekker, New York, NY 1982; 1–42
- Holmes WE, Lee J, Kuang W-J, Rice GC, Wood WI. Structure and functional expression of a human Interleukin-8 receptor. Science 1991; 253: 1278–1280
- Ings RMJ. The melanin binding of drugs and its implications. Drug Metabolism Reviews 1984; 15: 1183–1212
- Jung R. Qualitative and quantitative differences in the toxicity of chemicals to various species of animals. Basic science in toxicology, GN Volans, J Sims, FM Sullivan, P Turner. Taylor, London 1990; 103–112
- Legraverend C, Mode A, Westin S, Strom A, Eguchi H, Zaphiropoulos PG, Gustafsson JA. Transcriptional regulation of rat P-450 2C gene subfamily members by the sexually dimorphic pattern of growth hormone secretion. Molecular Endocrinology 1992; 6: 259–266
- Lin JH, Chiba M, Chen IW, Nishime IW, Vastag KJ. Sex-dependent pharmacokinetics of indinavir: In vivo and in vitro evidence. Drug Metabolism and Disposition 1996; 24: 1298–1306
- Lindquist NG. Accumulation of drugs on melanin. Acta Radiologica Suppl. 1973; 325: 1–92
- Lindup WE. Plasma protein binding of drugs — some basic and clinical aspects. Progress in drug metabolism, JW Bridges, LF Chasseaud, GG Gibson. Taylor and Francis, London 1987; 10: 141–185
- McDaniel HG, Podgainy H, Bressler R. The metabolism of tolbutamide in rat liver. Journal of Pharmacology and Experimental Therapy 1969; 167: 91–97
- Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991; 253: 1280–1283
- Petersen F, Flad H-D, Grandt E. Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways. Journal of Immunology, 152: 2467–2488
- Souza DG, Bertini R, Vieira AT, Cunha FQ, Poole S, Allegretti M, Colotta F, Teixeira MM. Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. British Journal of Pharmacology 2004; 143: 132–142
- Sullivan HR, Hanasono GK, Miller WM, Wood PG. Species specificity in the metabolism of nabilone. Relationship between toxicity and metabolic routes. Xenobiotica 1987; 17: 459–468
- Thompson KL, Vincent SH, Miller RR, Colletti AE, Alvaro RF, Wallace MA, Feeney WP, Chiu SH. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Drug Metabolism and Disposition 1997; 25: 1113–1118
- Veronese ME, McManus ME, Laupattarakasem P, Miners JO, Birkett DJ. Tolbutamide hydroxylation by human, rabbit, and rat liver microsomes and by purified forms of cytochrome P-450. Drug Metabolism and Disposition 1990; 18: 356–361
- Waxman DJ, Ram PA, Notani G, Leblanc GA, Alberta JA, Morrissey JJ, Sundseth SS. Pituitary regulation of the male-specific steroid 6β-hydroxylase P-450 2a (gene product IIIA2) in adult rat liver. Suppressive influence of growth hormone and thyroxine acting at a pretranslational level. Molecular Endocrinology 1990; 4: 447–454